Top Markets
#1 Black Phoenix Black Phoenix +354.49%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +75.51%
#4 Gold Park Gold Park +61.00%
#5 OpenEden OpenEden +38.44%
#6 Acurast Acurast +37.34%
#7 BasedHype BasedHype +27.03%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +21.32%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.03%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Rangering i aksjer #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Aksjekurs
$0.13607016
Sist synkronisert: 2024-09-10
Markedsverdi
$112.29K
Endring (1 dag)
22.46%
Endring (1 år)
0.00%
Land
GB
Handel BiVictriX Therapeutics Plc (BVX)

Kategori

Healthcare
Aksjeprishistorikk for BiVictriX Therapeutics Plc (BVX)
Høyeste sluttskurs: $0.11 den 2024-09-01

Laveste sluttskurs: $0.30 den 2021-08-01
Aksjeprishistorikk for BiVictriX Therapeutics Plc fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 -21.63%
2023 -33.60%
2022 -41.42%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE